European equities traded in the US as American depositary receipts were modestly higher late Thursday morning, rising 0.18% to 1,482.59 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company DBV (DBVT), which advanced 12% and 4.4% respectively. They were followed by accommodations booking site trivago (TRVG) and internet browser company Opera (OPRA), which increased 3.4% and 1.8%.
The decliners from continental Europe were led by financial services company ING (ING), which 0.6%. Also declining were oil and gas company Eni (E) and brewing company Anheuser-Busch InBev (BUD), which lost 0.5% and 0.2%.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Amarin (AMRN) and Akari Therapeutics (AKTX), which rose 4% and 1.8% respectively. Also climbing were software firm Endava (DAVA) medical device maker Smith & Nephew (SNN), which were up 2.5% and 1.1%.
The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana (NCNA) and Adaptimmune Therapeutics (ADAP), which dropped 24% and 2.9% respectively. They were followed by mining company BHP Group (BHP) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which were down 1.2% and nearly 1% respectively.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.